Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019

The coronavirus disease 2019 (COVID-19) pandemic started in Wuhan, Hubei Province, China, in December 2019, and by 24 April 2020, it had affected >2.73 million people in 185 countries and caused >192,000 deaths. Despite diverse societal measures to reduce transmission of the severe acute respi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ernest Spitzer, Ben Ren, Jasper J Brugts, Joost Daemen, Eugene McFadden, Jan GP Tijssen, Nicolas M Van Mieghem
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/1ebdf01778c24f519e49f3107d6ea9f3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1ebdf01778c24f519e49f3107d6ea9f3
record_format	dspace
spelling	oai:doaj.org-article:1ebdf01778c24f519e49f3107d6ea9f32021-12-04T16:02:43ZCardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 201910.15420/cfr.2020.072057-75592057-7540https://doaj.org/article/1ebdf01778c24f519e49f3107d6ea9f32020-05-01T00:00:00Zhttps://www.cfrjournal.com/articles/cardiovascular-clinical-trials-Coronavirus-COVID-19-pandemichttps://doaj.org/toc/2057-7540https://doaj.org/toc/2057-7559The coronavirus disease 2019 (COVID-19) pandemic started in Wuhan, Hubei Province, China, in December 2019, and by 24 April 2020, it had affected >2.73 million people in 185 countries and caused >192,000 deaths. Despite diverse societal measures to reduce transmission of the severe acute respiratory syndrome coronavirus 2, such as implementing social distancing, quarantine, curfews and total lockdowns, its control remains challenging. Healthcare practitioners are at the frontline of defence against the virus, with increasing institutional and governmental supports. Nevertheless, new or ongoing clinical trials, not related to the disease itself, remain important for the development of new therapies, and require interactions among patients, clinicians and research personnel, which is challenging, given isolation measures. In this article, the authors summarise the acute effects and consequences of the COVID-19 pandemic on current cardiovascular trials.Ernest SpitzerBen RenJasper J BrugtsJoost DaemenEugene McFaddenJan GP TijssenNicolas M Van MieghemRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENCardiac Failure Review , Vol 6, Iss , Pp - (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Ernest Spitzer Ben Ren Jasper J Brugts Joost Daemen Eugene McFadden Jan GP Tijssen Nicolas M Van Mieghem Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
description	The coronavirus disease 2019 (COVID-19) pandemic started in Wuhan, Hubei Province, China, in December 2019, and by 24 April 2020, it had affected >2.73 million people in 185 countries and caused >192,000 deaths. Despite diverse societal measures to reduce transmission of the severe acute respiratory syndrome coronavirus 2, such as implementing social distancing, quarantine, curfews and total lockdowns, its control remains challenging. Healthcare practitioners are at the frontline of defence against the virus, with increasing institutional and governmental supports. Nevertheless, new or ongoing clinical trials, not related to the disease itself, remain important for the development of new therapies, and require interactions among patients, clinicians and research personnel, which is challenging, given isolation measures. In this article, the authors summarise the acute effects and consequences of the COVID-19 pandemic on current cardiovascular trials.
format	article
author	Ernest Spitzer Ben Ren Jasper J Brugts Joost Daemen Eugene McFadden Jan GP Tijssen Nicolas M Van Mieghem
author_facet	Ernest Spitzer Ben Ren Jasper J Brugts Joost Daemen Eugene McFadden Jan GP Tijssen Nicolas M Van Mieghem
author_sort	Ernest Spitzer
title	Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
title_short	Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
title_full	Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
title_fullStr	Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
title_full_unstemmed	Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
title_sort	cardiovascular clinical trials in a pandemic: immediate implications of coronavirus disease 2019
publisher	Radcliffe Medical Media
publishDate	2020
url	https://doaj.org/article/1ebdf01778c24f519e49f3107d6ea9f3
work_keys_str_mv	AT ernestspitzer cardiovascularclinicaltrialsinapandemicimmediateimplicationsofcoronavirusdisease2019 AT benren cardiovascularclinicaltrialsinapandemicimmediateimplicationsofcoronavirusdisease2019 AT jasperjbrugts cardiovascularclinicaltrialsinapandemicimmediateimplicationsofcoronavirusdisease2019 AT joostdaemen cardiovascularclinicaltrialsinapandemicimmediateimplicationsofcoronavirusdisease2019 AT eugenemcfadden cardiovascularclinicaltrialsinapandemicimmediateimplicationsofcoronavirusdisease2019 AT jangptijssen cardiovascularclinicaltrialsinapandemicimmediateimplicationsofcoronavirusdisease2019 AT nicolasmvanmieghem cardiovascularclinicaltrialsinapandemicimmediateimplicationsofcoronavirusdisease2019
_version_	1718372721595777024

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019

Ejemplares similares